Biosensors for Point-of-Care Diagnostics Market Insights, Competitive Landscape, and Forecast - 2033 | Connected Wearables and Home-Based Testing Unlock $27.6 Billion by 2033

Growth opportunities center on wearable and multiplexed biosensors, digital health integration, telemedicine, strategic partnerships, product innovation and regional expansion


Dublin, Sept. 29, 2026 (GLOBE NEWSWIRE) -- "Biosensors for Point-of-Care Diagnostics Market Insights, Competitive Landscape, and Market Forecast - 2033" has been added to ResearchAndMarkets.com's offering.

The global Biosensors for Point-of-Care (POC) Diagnostics Market is projected to increase from USD 16.8 billion in 2026 to USD 27.6 billion by 2033, registering a compound annual growth rate (CAGR) of 4.0% during the forecast period. Market expansion is being supported by growing demand for rapid, accurate, and cost-effective diagnostic solutions that improve clinical decision-making and patient outcomes.

POC biosensors are gaining traction across glucose testing, cardiac marker detection, infectious disease screening, hormone analysis, cancer marker identification, coagulation testing, and fertility testing. The rising prevalence of chronic and infectious diseases, combined with greater awareness of early diagnosis, is increasing demand across hospitals, clinics, laboratories, assisted living healthcare centres, and home care environments.

Key Market Growth Drivers

  • Rising disease burden: The increasing incidence of diabetes, cardiovascular conditions, cancer, and infectious diseases is creating sustained demand for timely and reliable diagnostic testing.
  • Advances in biosensor technology: Developments in electrochemical, optical, thermal, and piezoelectric transducers are improving device sensitivity, accuracy, reliability, and application range.
  • Expansion of home-based healthcare: Consumer preference for convenient self-monitoring, particularly for glucose, fertility, pregnancy, and hormone testing, is accelerating product adoption.
  • Digital health integration: Miniaturized devices, smartphone compatibility, cloud connectivity, and remote data sharing are strengthening the role of POC biosensors in connected care.
  • Healthcare investment: Expanding medical infrastructure in emerging economies and government support for early disease detection are creating favorable market conditions.

Business Opportunities and Technology Trends

Healthcare technology companies, diagnostics manufacturers, and startups have significant opportunities to develop wearable biosensors, portable testing systems, and multiplexed diagnostic platforms that can analyze multiple biomarkers simultaneously. Integration with telemedicine and remote patient monitoring platforms is also expected to support chronic disease management and improve access to testing outside conventional clinical settings.

Strategic partnerships with hospitals, clinics, research laboratories, and home care service providers can help manufacturers accelerate product validation and commercialization. Companies are also investing in advanced materials, enhanced bioreceptors, and digital analysis capabilities to improve performance while reducing testing time and operational costs.

Regional Market Outlook

North America holds the largest share of the Biosensors for Point-of-Care Diagnostics Market. Its leadership is supported by advanced healthcare infrastructure, strong R&D capabilities, broad adoption of innovative medical technologies, and demand for home-based testing. The United States remains the region's primary market due to its established diagnostics sector and high healthcare expenditure.

Europe represents another major market, supported by public funding for healthcare innovation and initiatives focused on early disease detection. Germany, the UK, and France are among the leading national contributors.

Asia-Pacific is expected to record rapid growth as healthcare expenditure rises and diagnostic infrastructure expands. China, India, and Japan are key markets, driven by large patient populations, increasing awareness of preventive care, and a growing prevalence of lifestyle-related diseases.

Latin America and the Middle East and Africa offer developing opportunities as healthcare facilities improve and portable POC technologies gain wider acceptance, particularly in urban areas and regions with limited access to centralized laboratories.

Competitive Landscape

The market is highly competitive, with companies pursuing product launches, strategic collaborations, mergers and acquisitions, and geographic expansion. Continued R&D investment is supporting the introduction of biosensors with enhanced sensitivity, accuracy, connectivity, and functionality.

Prominent market participants include:

  • Danaher Corporation
  • Bio-Rad Laboratories Inc.
  • Zimmer & Peacock AS
  • Medtronic plc
  • Koninklijke Philips N.V.
  • Abbott Laboratories
  • Universal Biosensors, Inc.
  • Biosensors International Group, Ltd.
  • Johnson & Johnson
  • Masimo Corporation
  • QTL Biodetection LLC
  • Nova Biomedical
  • Innovative Sensor Technology IST AG
  • Siemens Healthineers AG
  • F. Hoffmann-La Roche Ltd.

Market Segmentation

By Product:

  • Biomarkers
  • Bioreceptors
  • Molecular Diagnostic Biosensors

By Transducer:

  • Thermal
  • Piezoelectric
  • Electrochemical
  • Optical

By Application:

  • Fertility/Pregnancy
  • Glucose Testing
  • HbA1c Testing
  • Infectious Disease
  • Cardiac Markers
  • Cancer Markers
  • Drugs of Abuse Testing
  • Coagulation Testing
  • Hormone Analysis
  • Others

By End User:

  • Clinics
  • Hospitals
  • Home Care Service Providers
  • Assisted Living Healthcare Centres
  • Research Laboratories

By Geographic Coverage:

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

With demand shifting toward decentralized, connected, and patient-focused diagnostics, the Biosensors for Point-of-Care Diagnostics Market is positioned for continued development through 2033. Innovation in wearable devices, multiplex testing, digital connectivity, and remote monitoring is expected to shape future competition and create new commercialization opportunities worldwide.

For more information about this report visit https://www.researchandmarkets.com/r/ijdghn

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

 

Contact Data

GlobeNewswire

Recommended Reading